SCHEMBL15799209

SCHEMBL15799209

FC(F)(F)c1cccc(N2CCCN3CC(Oc4cnc(C5CC5)cn4)CC3C2)n1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 19/20 0.38
▸ DGAT2 Q96PD7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15793381 1.00 ACACB (0.38) ACACBDGAT2
SCHEMBL15794132 1.00 ACACB (0.38) ACACBDGAT2
SCHEMBL15793892 1.00 ACACB (0.38) ACACBDGAT2
SCHEMBL15794283 1.00 ACACB (0.38) ACACBDGAT2
SCHEMBL14814694 0.95 ACACB (0.39) ACACB
SCHEMBL15793579 0.84 ACACB (0.37) ACACB
SCHEMBL15794243 0.84 ACACB (0.37) ACACB
SCHEMBL15793932 0.84 ACACB (0.37) ACACB
SCHEMBL15798562 0.84 ACACB (0.37) ACACB
SCHEMBL15793943 0.84 ACACB (0.37) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931727-A1 DIAZEPINE DERIVATIVES USEFUL AS CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF PAIN Abbvie Inc. (US) 2015-10-21 — — EP disclosed
WO-2014093337-A1 DIAZEPINE DERIVATIVES USEFUL AS CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF PAIN ABBVIE, INC. (US) 2014-06-19 — — WO disclosed
Send feedback